Literature DB >> 17927899

Antioxidant and anti-hyperglycemic activity of polysaccharide isolated from Dendrobium chrysotoxum Lindl.

Yaping Zhao1, Young-Ok Son, So-Soon Kim, Yong-Suk Jang, Jeong-Chae Lee.   

Abstract

Although polysaccharide is believed to play an important role in the medicinal effect of Dendrobium chrysotoxum Lindl (DCL), its role as an antioxidant and in anti-hyperglycemic induction was not reported. In this study, polysaccharide with molecular weight of approximately 150 kDa, herein named DCLP, was isolated from the stem of DCL, and its antioxidative, hypoglycemic and immune stimulating effects were evaluated using various in vitro and in vivo assay systems. DCLP inhibited hydroxyl radicals (*OH)-mediated deoxyribose degradation by scavenging hydroxyl radicals directly as well as by chelating iron ions. DCLP also showed dose-dependent scavenging activity on superoxide anions (O2*) and offered significant protection (p < 0.001) against glucose oxidasemediated cytotoxicity in Jurkat cells. DCLP had immune stimulating effects, as evidenced by the DCLP-mediated increases in the level of DNA synthesis, viability, and cytokine secretion in mouse lymphocytes. Moreover, oral administration of DCLP produced a significant reduction in blood glucose level in alloxan-induced diabetic mice. These findings suggest that DCLP has a potential utility in treating patients who require enhanced antioxidation, immune function and/or hypoglycemic activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17927899     DOI: 10.5483/bmbrep.2007.40.5.670

Source DB:  PubMed          Journal:  J Biochem Mol Biol        ISSN: 1225-8687


  15 in total

1.  Polysaccharides of Dendrobium officinale inhibit TNF-α-induced apoptosis in A-253 cell line.

Authors:  L Xiang; C W Stephen Sze; T B Ng; Y Tong; P C Shaw; C W Sydney Tang; Y B Kalin Zhang
Journal:  Inflamm Res       Date:  2012-12-25       Impact factor: 4.575

2.  In vitro antioxidant of a water-soluble polysaccharide from Dendrobium fimhriatum Hook.var.oculatum Hook.

Authors:  Aoxue Luo; Yijun Fan
Journal:  Int J Mol Sci       Date:  2011-06-17       Impact factor: 5.923

3.  A pharmacological appraisal of medicinal plants with antidiabetic potential.

Authors:  Vasim Khan; Abul Kalam Najmi; Mohd Akhtar; Mohd Aqil; Mohd Mujeeb; K K Pillai
Journal:  J Pharm Bioallied Sci       Date:  2012-01

Review 4.  Ancient records and modern research on the mechanisms of chinese herbal medicines in the treatment of diabetes mellitus.

Authors:  Hai-Ming Zhang; Feng-Xia Liang; Rui Chen
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-01       Impact factor: 2.629

5.  Establishment of an efficient in vitro regeneration protocol for rapid and mass propagation of Dendrobium chrysotoxum Lindl. using seed culture.

Authors:  Potshangbam Nongdam; Leimapokpam Tikendra
Journal:  ScientificWorldJournal       Date:  2014-10-20

6.  Dendrobium chrysotoxum Lindl. alleviates diabetic retinopathy by preventing retinal inflammation and tight junction protein decrease.

Authors:  Zengyang Yu; Chenyuan Gong; Bin Lu; Li Yang; Yuchen Sheng; Lili Ji; Zhengtao Wang
Journal:  J Diabetes Res       Date:  2015-01-01       Impact factor: 4.011

7.  Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway.

Authors:  Yonggang Xu; Rong Fang; Jie Shao; Zihao Cai
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

8.  Extraction Optimization, Preliminary Characterization and Bioactivities in Vitro of Ligularia hodgsonii Polysaccharides.

Authors:  Xueping Song; Jun Tang
Journal:  Int J Mol Sci       Date:  2016-05-21       Impact factor: 5.923

Review 9.  Dendrobium: Sources of Active Ingredients to Treat Age-Related Pathologies.

Authors:  Veronika Cakova; Frederic Bonte; Annelise Lobstein
Journal:  Aging Dis       Date:  2017-12-01       Impact factor: 6.745

10.  Subchronic and Genetic Safety Assessment of a New Medicinal Dendrobium Species: Dendrobium Taiseed Tosnobile in Rats.

Authors:  Li-Chan Yang; Jiunn-Wang Liao; Chi-Luan Wen; Wen-Chuan Lin
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-06       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.